Akebia Therapeutics
AKBA
AKBA
143 hedge funds and large institutions have $203M invested in Akebia Therapeutics in 2025 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 64 increasing their positions, 25 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.46% more ownership
Funds ownership: 31.1% → 36.56% (+5.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
45% less call options, than puts
Call options by funds: $654K | Put options by funds: $1.19M
Holders
143
Holding in Top 10
1
Calls
$654K
Puts
$1.19M
Top Buyers
| 1 | +$9.55M | |
| 2 | +$5.62M | |
| 3 | +$4.8M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$4.77M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.35M |
Top Sellers
| 1 | -$236K | |
| 2 | -$187K | |
| 3 | -$129K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$119K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$110K |
